$1.3m Biomedical Catalyst Grant Awarded for Neurodegeneration Studies
Home » $1.3m Biomedical Catalyst Grant Awarded for Neurodegeneration Studies
$1.3m Biomedical Catalyst Grant Awarded for Neurodegeneration Studies
Chronos Therapeutics has been awarded $1.3m grant for new work on neurodegeneration by the UK Innovation Agency the Technology Strategy Board.
$1.3m Biomedical Catalyst Grant Awarded for Neurodegeneration Studies2013-08-192013-08-19https://chronosthera.wpengine.com/wp-content/uploads/2017/09/vector-smart-object025x.pngChronos Therapeuticshttps://chronosthera.wpengine.com/wp-content/uploads/2017/09/vector-smart-object025x.png200px200px